News

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...
The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...
Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
More than half a million Brits are thought to be now relying on weight loss drugs like Ozempic and Mounjaro, amid a steady ...
Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...
Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...
Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...
Experts say the right diet may offer the same effects as Ozempic by curbing hunger and promoting steady weight loss.
The undertaking to Delhi HC follows a patent infringement plea filed by the Danish drugmaker against Dr Reddy’s Laboratories ...